Biolab strengthens its Advisory Board with former president of BB, CEO of 3M and former CTO of Itaú

Paraíba Confidential | February 11, 2025

As part of its strategic restructuring to boost sustainable growth, Biolab Farmacêutica has announced changes to its Advisory Board. CEO Fabio Amorosino takes over as interim chairman of the board, which also includes founding partners Cleiton Castro Marques, Dante Alario and Paulo Castro Marques. In addition, three new independent directors have been brought in to bring perspectives and experiences that will strengthen the future of the organization.

Cassio Casseb joins the board to bring his expertise in the financial and business sectors. Having worked for important organizations and strategic leaders, such as the president of Banco do Brasil, Grupo Pão de Açúcar and Coinbra (Dreyfus Group), among others, Cassio will contribute to Biolab with his vision of governance and his commitment to significant results. "I am honored to be part of a company that combines innovation and purpose, and I hope to add my experience to Biolab's success," he said.

João Bezerra Leite, former CTO (Chief Technology Officer) of Itaú Unibanco, has a relevant background in technology and innovation, and joined the Board in November with the aim of boosting Biolab's progress in the digital age. His experience is and will be decisive in driving forward new technologies and the company's operational efficiency. "I am very pleased to be part of projects with purpose and impact like Biolab, in an environment with solid values and surrounded by people who want to transform and from whom I can learn," says João Bezerra.

Paulo Gandolfi, the current CEO of 3M Brazil, brings to the board his vast experience in Research, Development and Innovation (RD&I), aligned with the strategies of various units in the business. His ability to lead multifunctional operations and integrate global strategies will be essential to increasing Biolab's leading role in the health sector. "It's a privilege to contribute to a company recognized for its focus on RD&I and commitment to excellence," says Gandolfi.
With a strengthened Advisory Board, Biolab reaffirms its commitment to innovation, sustainability and the creation of value for the healthcare market, maintaining its position as a benchmark in the sector.

See the full article: Biolab strengthens its Advisory Board with former president of BB, CEO of 3M and former CTO of Itaú